(Q41225055)

28 September 2017

1 reference

title

Clinical review of once-daily beclomethasone dipropionate for seasonal allergic rhinitis (English)

1 reference

beclomethasone dipropionate

28 September 2017

main subject

1 reference

Chervinsky P

1

1 reference

28 September 2017

publication date

1 September 1996

1 reference

28 September 2017

published in

Clinical Therapeutics

1 reference

28 September 2017

volume

18

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

790-6; discussion 789

1 reference

Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Mode of action of corticosteroids in asthma and rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Effect of topical corticosteroids on the recovery of histamine releasing factors in nasal washings of patients with allergic rhinitis. A double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Effectiveness and safety of beclomethasone dipropionate, an intranasal corticosteroid, in the treatment of patients with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Beclomethasone dipropionate aerosol in treatment of hay fever in children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Beclomethasone dipropionate aerosol in treatment of perennial allergic rhinitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Clinical, rhinomanometric, and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Onset of action of aqueous beclomethasone dipropionate nasal spray in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Double-strength beclomethasone dipropionate (84 micrograms/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

An overview of current pharmacotherapy in perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Effect of beclomethasone dipropionate nasal aerosol on serum markers of bone metabolism in children with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Effects of beclomethasone dipropionate aerosol on nasal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

Long-Term Follow-up of Intra-Nasal Beclomethasone Treatment a Clinical and Histologic Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

A meta-analysis of the effect of oral and inhaled corticosteroids on growth

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980039-7

7 January 2021

10.1016/S0149-2918(96)80039-7

Identifiers

DOI

1 reference

28 September 2017

1 reference